Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients

ClinicalTrials.gov ID: NCT05035641

Public ClinicalTrials.gov record NCT05035641. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 7:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pilot Phase II Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Dose-Ranging, Safety and Efficacy Study of Oral AND017 to Treat Anemia in Nondialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a pilot phase II study to evaluate the safety and efficacy of AND017 in NDD-CKD patients

Study identification

NCT ID
NCT05035641
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Kind Pharmaceuticals LLC
Industry
Enrollment
113 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
20 Years to 74 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 18, 2021 (Actual)
Primary completion
Jul 5, 2023 (Actual)
Completion
Jul 24, 2023 (Actual)
Last update posted
Oct 4, 2023

2021 – 2023

United States locations

U.S. sites
7
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
Amicis Research Center Northridge California 91324 —
Clinical Site Partners Winter Park Florida 32789 —
Northwest Louisiana Nephrology Shreveport Louisiana 71101 —
Elite Research Center Flint Michigan 48532 —
Metrolina Nephrology Associates Charlotte North Carolina 28207 —
Southeast Renal Research Institute Chattanooga Tennessee 37404 —
Clinical Advancement Center, PLLC San Antonio Texas 78212 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05035641, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 4, 2023 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05035641 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →